Largest health care companies by earnings
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Johnson & Johnson leads the 170 health care companies ranked by earnings, at DKK 182.4B, ahead of Eli Lilly (DKK 140.5B) and Merck & Co (DKK 124.2B). Figures as of 19 Nov 2026, 15:57 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 170
- First
- Johnson & JohnsonDKK 182.4B
- Median
- DKK 1.9B
- Combined market value
- DKK 60.77T
- Countries
- 14
Market values as of .
All countries▾
Health Care▾
All categories▾
| # | Company | Earnings ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 101 | Hims & Hers HealthHIMS · Health Care | DKK 873.6M | DKK 26.4B | DKK 112.50 | 3.05% down | 49% down | ||
| 102 | Ligand PharmaceuticalsLGND · Health Care | DKK 847M | DKK 39.3B | DKK 1,967.04 | 3.24% down | 50% up | ||
| 103 | Corcept TherapeuticsCORT · Health Care | DKK 678.2M | DKK 48.5B | DKK 442.81 | 4.02% down | 10% down | ||
| 104 | HaemoneticsHAE · Health Care | DKK 662.2M | DKK 37.2B | DKK 816.75 | 2.32% down | 64% up | ||
| 105 | Amneal PharmaceuticalsAMRX · Health Care | DKK 490.4M | DKK 50.5B | DKK 144.89 | 2.70% down | 90% up | ||
| 106 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | DKK 401.6M | DKK 50.4B | DKK 641.71 | 0.80% down | 129% up | ||
| 107 | RepligenRGEN · Health Care | DKK 332.8M | DKK 76.5B | DKK 1,196.47 | 1.82% up | 12% up | ||
| 108 | LifeStance Health GroupLFST · Health Care | DKK 65.8M | DKK 34.4B | DKK 90.48 | 3.45% down | 123% up | ||
| 109 | BillionToOneBLLN · Health Care | DKK 50.7M | DKK 29.4B | DKK 615.37 | 1.22% down | 4% down | ||
| 110 | Arrowhead PharmaceuticalsARWR · Health Care | -DKK 11.1M | DKK 41.8B | DKK 295.33 | 0.66% up | 13% up | ||
| 111 | BrukerBRKR · Health Care | -DKK 58.5M | DKK 66.7B | DKK 436.52 | 1.39% up | 44% up | ||
| 112 | RadNetRDNT · Health Care | -DKK 126.9M | DKK 37.5B | DKK 476.67 | 2.48% down | 9% down | ||
| 113 | Mirum PharmaceuticalsMIRM · Health Care | -DKK 159M | DKK 41.6B | DKK 637.16 | 1.22% up | 34% up | ||
| 114 | Travere TherapeuticsTVTX · Health Care | -DKK 173.9M | DKK 32.3B | DKK 336.57 | 1.56% down | 45% up | ||
| 115 | 10x GenomicsTXG · Health Care | -DKK 296.3M | DKK 53.9B | DKK 409.47 | 5.42% up | 247% up | ||
| 116 | Adaptive BiotechnologiesADPT · Health Care | -DKK 404.9M | DKK 31.8B | DKK 196.68 | 1.55% up | 74% up | ||
| 117 | Caris Life SciencesCAI · Health Care | -DKK 463.4M | DKK 38.4B | DKK 133.77 | 0.79% up | 19% down | ||
| 118 | VeradermicsMANE · Health Care | -DKK 476.4M | DKK 35.6B | DKK 843.05 | 0.79% down | 231% up | ||
| 119 | Belite BioBLTE · Health Care | -DKK 528.2M | DKK 41.8B | DKK 1,029.63 | 3.16% down | 43% up | ||
| 120 | Twist BioscienceTWST · Health Care | -DKK 528.6M | DKK 56B | DKK 820.76 | 3.65% up | 346% up | ||
| 121 | Oruka TherapeuticsORKA · Health Care | -DKK 717.5M | DKK 45.1B | DKK 665.63 | 2.16% up | 255% up | ||
| 122 | HeartflowHTFL · Health Care | -DKK 794.8M | DKK 26.9B | DKK 306.59 | 1.83% down | 66% up | ||
| 123 | ErascaERAS · Health Care | -DKK 847.6M | DKK 33.3B | DKK 94.94 | 1.38% up | 395% up | ||
| 124 | Protagonist TherapeuticsPTGX · Health Care | -DKK 885.7M | DKK 56.1B | DKK 859.42 | 0.69% down | 51% up | ||
| 125 | Charles River Laboratories InternationalCRL · Health Care | -DKK 982.3M | DKK 109B | DKK 2,273.70 | 0.25% up | 106% up | ||
| 126 | Spyre TherapeuticsSYRE · Health Care | -DKK 1.1B | DKK 63.4B | DKK 667.40 | 3.35% down | 332% up | ||
| 127 | CG OncologyCGON · Health Care | -DKK 1.1B | DKK 49.5B | DKK 554.22 | 1.79% up | 97% up | ||
| 128 | Dianthus TherapeuticsDNTH · Health Care | -DKK 1.1B | DKK 32.6B | DKK 579.77 | 1.44% up | 108% up | ||
| 129 | Edgewise TherapeuticsEWTX · Health Care | -DKK 1.1B | DKK 30.3B | DKK 276.51 | 1.79% down | 86% up | ||
| 130 | Axsome TherapeuticsAXSM · Health Care | -DKK 1.2B | DKK 47.7B | DKK 906.99 | 0.54% down | 6% down | ||
| 131 | Definium TherapeuticsDFTX · Health Care | -DKK 1.3B | DKK 26.6B | DKK 194.37 | 1.92% down | 168% up | ||
| 132 | GlaukosGKOS · Health Care | -DKK 1.3B | DKK 94.6B | DKK 1,597.73 | 0.72% up | 145% up | ||
| 133 | Rhythm PharmaceuticalsRYTM · Health Care | -DKK 1.3B | DKK 55.2B | DKK 796.06 | 1.74% down | 18% up | ||
| 134 | NateraNTRA · Health Care | -DKK 1.4B | DKK 294.7B | DKK 2,032.44 | 3.16% up | 28% up | ||
| 135 | Kodiak SciencesKOD · Health Care | -DKK 1.6B | DKK 42.8B | DKK 654.23 | 1.72% down | 399% up | ||
| 136 | Elanco Animal HealthELAN · Health Care | -DKK 1.6B | DKK 90.8B | DKK 181.71 | 0.00% | 26% up | ||
| 137 | LivaNovaLIVN · Health Care | -DKK 1.7B | DKK 34.8B | DKK 631.09 | 1.91% down | 77% up | ||
| 138 | Ascendis PharmaASND · Health Care | -DKK 1.7B | DKK 118.6B | DKK 1,807.55 | 1.75% down | 29% up | ||
| 139 | Madrigal PharmaceuticalsMDGL · Health Care | -DKK 2B | DKK 63B | DKK 2,710.29 | 0.04% up | 27% down | ||
| 140 | Legend BiotechLEGN · Health Care | -DKK 2B | DKK 21B | DKK 108.21 | 2.15% down | 41% down | ||
| 141 | Roivant SciencesROIV · Health Care | -DKK 2B | DKK 193.1B | DKK 266.51 | 1.11% up | 91% up | ||
| 142 | Praxis Precision MedicinesPRAX · Health Care | -DKK 2.1B | DKK 60B | DKK 2,148.31 | 3.43% up | 86% up | ||
| 143 | Kymera TherapeuticsKYMR · Health Care | -DKK 2.1B | DKK 68.7B | DKK 804.63 | 2.39% down | 87% up | ||
| 144 | Cogent BiosciencesCOGT · Health Care | -DKK 2.2B | DKK 33B | DKK 189.54 | 0.14% up | 20% down | ||
| 145 | MiniMed GroupMMED · Health Care | -DKK 2.3B | DKK 31.2B | DKK 111.03 | 3.97% down | 8% down | ||
| 146 | ImmunityBioIBRX · Health Care | -DKK 2.4B | DKK 46.8B | DKK 44.03 | 3.43% down | 232% up | ||
| 147 | Jazz PharmaceuticalsJAZZ · Health Care | -DKK 2.4B | DKK 104.6B | DKK 1,630.13 | 3.33% down | 41% up | ||
| 148 | Bausch + LombBLCO · Health Care | -DKK 2.5B | DKK 50.6B | DKK 141.56 | 0.72% down | 44% up | ||
| 149 | ABIVAXABVX · Health Care | -DKK 2.5B | DKK 50.4B | DKK 576.03 | 0.97% up | 32% down | ||
| 150 | Scholar Rock HoldingSRRK · Health Care | -DKK 2.6B | DKK 41B | DKK 335.79 | 2.79% up | 26% up | ||
| 151 | Ionis PharmaceuticalsIONS · Health Care | -DKK 2.6B | DKK 30.6B | DKK 183.45 | 1.59% down | 63% down | ||
| 152 | GRAILGRAL · Health Care | -DKK 2.8B | DKK 33.1B | DKK 736.51 | 5.99% up | 19% up | ||
| 153 | Guardant HealthGH · Health Care | -DKK 2.8B | DKK 139.5B | DKK 1,031.19 | 4.40% up | 45% up | ||
| 154 | Oscar HealthOSCR · Health Care | -DKK 3B | DKK 56.2B | DKK 180.89 | 3.59% down | 112% up | ||
| 155 | ImmunovantIMVT · Health Care | -DKK 3.4B | DKK 46.3B | DKK 223.63 | 0.93% down | 46% up | ||
| 156 | AvantorAVTR · Health Care | -DKK 3.6B | DKK 70.5B | DKK 103.99 | 0.59% down | 40% up | ||
| 157 | CRISPR TherapeuticsCRSP · Health Care | -DKK 4B | DKK 26.6B | DKK 274.54 | 0.37% up | 18% down | ||
| 158 | BridgeBio PharmaBBIO · Health Care | -DKK 5B | DKK 104B | DKK 534.11 | 0.60% up | 21% up | ||
| 159 | VaxcytePCVX · Health Care | -DKK 5.2B | DKK 63.6B | DKK 401.70 | 0.86% up | 23% up | ||
| 160 | CytokineticsCYTK · Health Care | -DKK 5.3B | DKK 48.1B | DKK 345.05 | 1.21% down | 19% down | ||
| 161 | TeleflexTFX · Health Care | -DKK 6.2B | DKK 44.4B | DKK 1,119.39 | 0.83% down | 58% up | ||
| 162 | Takeda PharmaceuticalTAK · Health Care | -DKK 6.5B | DKK 465.1B | DKK 145.57 | 0.56% up | 51% up | ||
| 163 | Baxter InternationalBAX · Health Care | -DKK 6.5B | DKK 89.5B | DKK 173.00 | 2.83% down | 50% up | ||
| 164 | Summit TherapeuticsSMMT · Health Care | -DKK 7.3B | DKK 57.4B | DKK 71.73 | 0.38% up | 36% down | ||
| 165 | Revolution MedicinesRVMD · Health Care | -DKK 7.7B | DKK 239.7B | DKK 1,108.10 | 1.88% up | 129% up | ||
| 166 | BioNTechBNTX · Health Care | -DKK 8.6B | DKK 138.6B | DKK 558.88 | 1.37% down | 14% down | ||
| 167 | InsmedINSM · Health Care | -DKK 8.7B | DKK 206.8B | DKK 942.58 | 15.61% up | 40% down | ||
| 168 | ModernaMRNA · Health Care | -DKK 19.2B | DKK 541.5B | DKK 1,338.20 | 0.08% down | 780% up | ||
| 169 | ViatrisVTRS · Health Care | -DKK 23.9B | DKK 154.4B | DKK 134.72 | 2.39% down | 99% up | ||
| 170 | CenteneCNC · Health Care | -DKK 45.4B | DKK 216.3B | DKK 436.92 | 4.82% down | 94% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Earnings is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 6.8057 DKK).
Questions and answers
Which health care companies rank first by earnings?
Johnson & Johnson (DKK 182.4B), Eli Lilly (DKK 140.5B) and Merck & Co (DKK 124.2B) are the top three of the 170 health care companies ranked by earnings as of 19 Nov 2026, 15:57 UTC.
How many health care companies are in this ranking?
170 are ranked by earnings.
What are these health care companies worth together?
The 170 health care companies ranked by earnings have a combined market value of DKK 60.77T as of 19 Nov 2026, 15:57 UTC.
What does ranking by earnings measure?
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest health care companies by earnings”, data as of 19 November 2026. https://funkfolio.com/companies/sector/health-care?by=earnings
Underlying data: Yahoo Finance; SEC EDGAR.